• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic field safety notice in Europe involves potentially serious HVAD problem

Medtronic field safety notice in Europe involves potentially serious HVAD problem

April 9, 2020 By Sean Whooley

Medtronic logo updatedMedtronic (NYSE:MDT) issued a field safety notice in Europe to warn on potential damage occurring during pre-implant procedures with its HeartWare HVAD system.

The Fridley, Minn.-based company’s HVAD heart pump has an outflow graft that may be subject to tears, and its strain relief screw may break during the pre-implant pump assembly and attachment to the HVAD pump.

Medtronic said in the notice that it is offering additional steps for assembly and attachment to reduce the risk of tears and damage. No action is needed for patients who are currently implanted with an HVAD pump because the potential for damage applies to the pre-implant outflow graft and strain relief assembly procedure, so the company is not retrieving the product from the field.

Affected products include the HVAD pump outflow graft, model number 1125, HVAD pump implant kit, model number 1104, and the HVAD implant accessories kit, model number 1153.

The company received 92 complaints related to the issue after distributing nearly 22,000 HVAD pumps through March 5, 2020. In total, Medtronic reported two deaths associated with the outflow graft tears and two deaths related to subsequent complications after outflow graft intervention.

Medtronic received 54 total complaints related to the outflow graft tears, which can result in peri-operative and post-operative bleeding. The company also received 38 complaints related to the broken strain relief screws with no reported patient harm in relation to that particular issue. Product damage was identified prior to or during implant in 74 cases and post-implant in 18 cases.

The company said it is working with regulatory agencies for approval of a design change that is intended to reduce the risk of damage related to these issues and will provide training on the change after approval is obtained. Users are urged to closely inspect the graft after assembly and before implantation, while physicians were instructed to practice standard peri-operative and immediate post-operative patient management to detect for the issue.

Filed Under: Cardiovascular, Featured, Recalls, Regulatory/Compliance, Structural Heart Tagged With: Medtronic

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy